Versartis Inc (VSAR)

16.10
NASDAQ : Health Care
Prev Close 16.10
Day Low/High 0.00 / 0.00
52 Wk Low/High 8.69 / 24.00
Avg Volume 294.80K
Exchange NASDAQ
Shares Outstanding 35.21M
Market Cap 570.39M
EPS -3.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Versartis Announces Three Year Somavaratan Data At ENDO 2017 Showing Safety And Efficacy In Line With Historical U.S. Daily RhGH Data In Pediatric GHD

Versartis Announces Three Year Somavaratan Data At ENDO 2017 Showing Safety And Efficacy In Line With Historical U.S. Daily RhGH Data In Pediatric GHD

- Mean height velocity during Years 1, 2, and 3 remained consistent and in line with U.S. daily rhGH treatment

Versartis Reports New Data On Long-Acting Somavaratan In Growth Hormone Deficiency At ENDO 2017

Versartis Reports New Data On Long-Acting Somavaratan In Growth Hormone Deficiency At ENDO 2017

- Baseline characteristics of Phase 3 VELOCITY trial population balanced between study arms and comparable to Phase 2

Twitter Is One of Five Stocks Insiders Really Love Right Now

Twitter Is One of Five Stocks Insiders Really Love Right Now

Insiders at these companies have been scooping up shares in their own organizations lately.

Versartis' Pipeline Holds Big Promise

Versartis' Pipeline Holds Big Promise

This small-cap biotech name could have further to run.

Versartis' Pipeline Holds Big Promise

Versartis' Pipeline Holds Big Promise

This small-cap biotech name could have further to run.

Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy

Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy

Insiders at Infinity Pharmaceuticals and Och-Ziff Capital Management Group -- among other companies -- have been scooping up shares of their own stock lately.

Commit To Buy Versartis At $10, Earn 46.5% Annualized Using Options

Commit To Buy Versartis At $10, Earn 46.5% Annualized Using Options

Investors eyeing a purchase of Versartis Inc stock, but cautious about paying the going market price of $12.25/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $10 strike, which has a bid at the time of this writing of $1.35.

Versartis Presents Safety, Efficacy And IGF-I Data For Somavaratan In Pediatric Growth Hormone Deficiency At The 2016 Congress Of The GRS & IGF Society

Versartis Presents Safety, Efficacy And IGF-I Data For Somavaratan In Pediatric Growth Hormone Deficiency At The 2016 Congress Of The GRS & IGF Society

Increasing somavaratan dose to the 3.5mg/kg twice-monthly now used in Phase 3 safely improved IGF-I SDS and height velocity from year 1 to year 2

Versartis Enters Oversold Territory (VSAR)

Versartis Enters Oversold Territory (VSAR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Shark Bites: Versartis Is a Biotech Worth Tracking

Shark Bites: Versartis Is a Biotech Worth Tracking

Biotechnology stocks can be risky but it's helpful to track them over time.

Short Interest Decreases By 26.6% For VSAR

Short Interest Decreases By 26.6% For VSAR

The most recent short interest data has been released for the 09/15/2016 settlement date, which shows a 352,820 share decrease in total short interest for Versartis Inc , to 974,210, a decrease of 26.59% since 08/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.